//--> //--> //--> //-->
Toggle navigation
Logout
Change account settings
EN
DE
ES
FR
A-Z
Beta
About EconBiz
News
Thesaurus (STW)
Research Skills
Help
EN
DE
ES
FR
My account
Logout
Change account settings
Login
Publications
Events
Your search terms
Search
Search options
All Fields
Title
Exact title
Subject
Author
Institution
ISBN/ISSN
Published in...
Publisher
Open Access only
Advanced
Search history
My EconBiz
Favorites
Loans
Reservations
Fines
You are here:
Home
Does Reference Pricing Drive O...
Similar by subject
Narrow search
Narrow search
Year of publication
From:
To:
Subject
All
Wirkungsanalyse
79,123
Impact assessment
77,008
Norwegen
19,069
Theorie
15,207
Theory
14,561
Coronavirus
13,956
Norway
12,134
Welt
9,763
World
9,583
USA
9,316
United States
8,956
EU-Staaten
8,526
Deutschland
8,330
Schätzung
8,233
EU countries
8,226
Estimation
7,882
Arzneimittel
7,832
Pharmaceuticals
7,823
Germany
7,404
Geldpolitik
6,917
Monetary policy
6,718
Epidemie
5,657
Epidemic
5,655
COVID-19
5,106
Wirtschaftswachstum
4,307
Price discrimination
4,204
Economic growth
4,157
Preisdifferenzierung
4,156
Finanzkrise
4,123
Financial crisis
4,064
China
3,990
Preiswettbewerb
3,601
Price competition
3,524
Großbritannien
3,450
Finanzpolitik
3,431
Fiscal policy
3,346
Arbeitsmarktpolitik
3,279
Schock
3,254
India
3,220
Shock
3,206
more ...
less ...
Online availability
All
Free
72,456
Undetermined
26,265
Type of publication
All
Book / Working Paper
95,507
Article
52,225
Journal
660
Other
19
Database
3
Type of publication (narrower categories)
All
Article in journal
37,162
Aufsatz in Zeitschrift
37,162
Graue Literatur
34,035
Non-commercial literature
34,035
Working Paper
33,591
Arbeitspapier
27,236
Aufsatz im Buch
6,207
Book section
6,207
Hochschulschrift
2,871
Thesis
2,125
Amtsdruckschrift
1,957
Government document
1,957
Collection of articles of several authors
1,913
Sammelwerk
1,913
Aufsatzsammlung
958
Article
955
Konferenzschrift
740
Conference paper
614
Konferenzbeitrag
614
Advisory report
555
Gutachten
555
Statistik
534
Collection of articles written by one author
467
Sammlung
467
Case study
453
Fallstudie
453
Research Report
438
Bibliografie enthalten
427
Bibliography included
427
Conference proceedings
382
Statistics
314
Conference Paper
241
Amtliche Publikation
229
No longer published / No longer aquired
211
Systematic review
206
research-article
206
Übersichtsarbeit
206
Forschungsbericht
187
Mehrbändiges Werk
118
Multi-volume publication
118
more ...
less ...
Language
All
English
114,160
Undetermined
17,528
German
9,143
Norwegian
4,235
French
1,106
Spanish
964
Russian
345
Portuguese
313
Italian
247
Swedish
192
Polish
152
Danish
108
Dutch
89
Hungarian
72
Czech
47
Finnish
42
Serbian
42
Romanian
39
Ukrainian
32
Slovak
22
Slovenian
18
Croatian
15
Bulgarian
12
Korean
10
Lithuanian
9
Macedonian
9
Chinese
7
Estonian
4
Modern Greek (1453-)
3
Multiple languages
3
Norwegian Bokmål
3
Turkish
3
Bosnian
2
Japanese
2
Old Norse
2
Albanian
2
Valencian
1
Persian
1
Middle High German
1
Hebrew
1
more ...
less ...
Author
All
Salvanes, Kjell G.
394
Lechner, Michael
257
Lambertini, Luca
248
Ziebarth, Nicolas R.
224
Mogstad, Magne
200
Straume, Odd Rune
193
Costa-Font, Joan
190
Heckman, James J.
184
Matsushima, Noriaki
172
Caliendo, Marco
167
Schmidt, Christoph M.
158
Black, Sandra E.
144
Chen, Xi
144
Lichtenberg, Frank R.
141
Berndt, Ernst R.
136
Kluve, Jochen
134
Røed, Knut
130
Devereux, Paul J.
129
Brekke, Kurt R.
126
Siciliani, Luigi
126
Strøm, Steinar
126
Böhringer, Christoph
124
Fronstin, Paul
120
Haucap, Justus
118
Mukherjee, Arijit
116
Halla, Martin
115
Wey, Christian
114
Nilsen, Øivind Anti
112
Budzinski, Oliver
108
Kremer, Michael
107
Peitz, Martin
107
Raaum, Oddbjørn
106
Gruber, Jonathan
102
Kind, Hans Jarle
101
Dave, Dhaval
96
Karlsson, Martin
96
Neumark, David
93
Nymoen, Ragnar
90
Rees, Daniel I.
89
Huck, Steffen
88
more ...
less ...
Institution
All
National Bureau of Economic Research
2,317
Volkswirtschaftliche Fakultät, Ludwig-Maximilians-Universität München
785
National Bureau of Economic Research (NBER)
748
C.E.P.R. Discussion Papers
474
OECD
470
Université Paris-Dauphine (Paris IX)
299
Institute for the Study of Labor (IZA)
239
Norwegen / Statistisk sentralbyrå
197
Center for Operations Research and Econometrics (CORE), École des Sciences Économiques de Louvain
160
CESifo
153
World Bank
145
EconWPA
144
Norwegen
132
Helseøkonomisk Forskningsprogram (HERO), Universitetet i Oslo
117
Department of Economics and Related Studies, University of York
115
Österreichisches Institut für Wirtschaftsforschung
110
World Bank Group
102
Department of Economics and Business, Universitat Pompeu Fabra
87
Nordic Council of Ministers
84
Department of Economics, McMaster University
80
NET Institute
80
International Monetary Fund
79
Dipartimento di Scienze Economiche, Alma Mater Studiorum - Università di Bologna
77
Tinbergen Instituut
75
Institutet för Näringslivsforskning (IFN)
73
Tilburg University, Center for Economic Research
72
Adis International Limited
66
Institut für Weltwirtschaft
62
Institute for Prospective Technological Studies (IPTS), Joint Research Centre
62
Rheinisch-Westfälisches Institut für Wirtschaftsforschung (RWI)
62
London School of Economics (LSE)
61
Norges Bank
61
University of British Columbia - Centre for Health Services and Policy Research.
61
Europäische Kommission
60
Springer Fachmedien Wiesbaden
60
DIW Berlin (Deutsches Institut für Wirtschaftsforschung)
59
Economics Institute for Research (SIR), Handelshögskolan i Stockholm
57
Department of Economics, Oxford University
56
Institutt for Økonomi, Universitetet i Bergen
56
Organisation for Economic Co-operation and Development
56
more ...
less ...
Published in...
All
NBER working paper series
2,305
Discussion paper series / IZA
2,146
Working paper / National Bureau of Economic Research, Inc.
1,822
NBER Working Paper
1,633
PharmacoEconomics
1,437
IZA Discussion Paper
1,388
IZA Discussion Papers
1,383
CESifo working papers
1,178
CESifo Working Paper
950
Working paper
949
Discussion paper / Centre for Economic Policy Research
794
NBER Working Papers
745
MPRA Paper
697
Disease Management and Health Outcomes
608
CESifo Working Paper Series
598
Norges offentlige utredninger : N.O.U.
572
CEPR Discussion Papers
486
Working Paper
477
Discussion papers / CEPR
462
IMF working papers
449
Rapporter / Statistisk Sentralbyrå
444
Discussion paper
442
Applied economics
420
Energy economics
407
Policy research working paper : WPS
400
Wirtschaftsdienst : Zeitschrift für Wirtschaftspolitik
377
Sosialøkonomen
362
Economic modelling
349
Economics letters
345
World Bank E-Library Archive
330
Applied economics letters
291
Economics Papers from University Paris Dauphine
284
World development : the multi-disciplinary international journal devoted to the study and promotion of world development
282
Finance research letters
281
The American economic review
260
World Bank Policy Research Working Paper
259
IMF Working Paper
256
Applied Health Economics and Health Policy
252
American economic journal : a journal of the American Economic Association
246
GLO discussion paper
244
more ...
less ...
Source
All
ECONIS (ZBW)
123,712
RePEc
15,724
EconStor
8,077
USB Cologne (EcoSocSci)
370
Other ZBW resources
279
USB Cologne (business full texts)
122
BASE
71
OLC EcoSci
34
ArchiDok
25
more ...
less ...
Showing
51
-
60
of
148,414
Sort
relevance
articles prioritized
date (newest first)
date (oldest first)
51
Physicians as Double Agents in a Universal Health Care System : Evidence from Generic Pharmaceutical Adoption in Taiwan
Tang, Meng-Chi
-
2016
Physicians’ generic pharmaceutical adoption involves not only patients’ and insurance payers’ cost, but also their own interests. This study examines this double agency problem for physicians by using Taiwanese data because two of its institutional features: First, patients and physicians...
Persistent link: https://www.econbiz.de/10014129240
Saved in:
52
Consumer Information and Pharmaceutical Prices : Theory and Evidence
Granlund, David
;
Rudholm, Niklas
-
2023
of brand name
pharmaceuticals
, while the results regarding generics are less clear. In the empirical part of the paper …, the introduction of the substitution reform in the Swedish
pharmaceuticals
market in October 2002 is used as a natural … reform has lowered the price of both brand name and generic
pharmaceuticals
…
Persistent link: https://www.econbiz.de/10014260998
Saved in:
53
Generic Entry in a Regulated Pharmaceutical Market
Iizuka, Toshiaki
-
2014
This paper examines generic entry into the Japanese pharmaceutical market. Relatively little is known about generic entry in regulated markets. Using micro data between 2003 and 2005, I find that generic entry is sensitive to the prescription pattern driven by the price regulation and healthcare...
Persistent link: https://www.econbiz.de/10014210344
Saved in:
54
A Dynamic Oligopoly Structural Model for the Prescription Drug Market after Patent Expiration
Ching, Andrew T.
-
2012
Motivated by the slow diffusion of generic drugs and the increase in prices of brand-name drugs after generic entry, I incorporate consumer learning and consumer heterogeneity into an empirical dynamic oligopoly model. In the model, firms choose prices to maximize their expected total discounted...
Persistent link: https://www.econbiz.de/10012755155
Saved in:
55
Hospitals and the generic versus brand-name prescription decision in the outpatient sector
Pruckner, Gerald J.
;
Schober, Thomas
-
2016
Healthcare payers try to reduce costs by promoting the use of cheaper generic drugs. We show strong interrelations in drug prescriptions between the inpatient and outpatient sectors by using a large administrative dataset from Austria. Patients with prior hospital visits have a significantly...
Persistent link: https://www.econbiz.de/10011570769
Saved in:
56
Generic substitution
Furu, Kari
;
Dalen, Dag Morten
;
Locatelli Biey, Marilena
; …
-
2008
(chemical substances) in
Norway
, we find strong evidence for the importance of both doctor and patient characteristics for the …
Persistent link: https://www.econbiz.de/10003751872
Saved in:
57
Regulation and pricing of
pharmaceuticals
: reference pricing or price cap regulation?
Brekke, Kurt R.
;
Grasdal, Astrid L.
;
Holmås, Tor Helge
-
2007
experiment from
Norway
, which in 2003 introduced a reference price (RP) system called index pricing for a sub-sample of off …-patent
pharmaceuticals
, replacing the existing price cap (PC) regulation. We estimate the effect of the reform using a product level panel …
Persistent link: https://www.econbiz.de/10010264178
Saved in:
58
Direct-to-Consumer Advertising in Pharmaceutical Markets
Brekke, Kurt Richard
;
Kuhn, Michael
-
2021
We study effects of direct-to-consumer advertising (DTCA) in the prescription drug market. There are two pharmaceutical firms providing horizontally differentiated (branded) drugs. Patients differ in their susceptibility to the drugs. If DTCA is allowed, this can be employed to induce...
Persistent link: https://www.econbiz.de/10013318409
Saved in:
59
Evaluating the US pharmaceutical patent policy
Izhak, Olena
;
Saxell, Tanja
;
Takalo, Tuomas
-
2021
The debate on whether COVID-19 vaccine patents are slowing down the pace of vaccination and the recovery from the crisis has brought the optimal design of pharmaceutical patent policy to the fore. In this paper we evaluate patent policy in the US pharmaceutical industry. We estimate the effect...
Persistent link: https://www.econbiz.de/10012802183
Saved in:
60
The Economics Behind the Epidemic : Afghan Opium Price and Prescription Opioids in the US
Deiana, Claudio
-
2020
We investigate the effect of variations in the price of opium in Afghanistan on per capita dispensation of prescription opioids in the US. Quarterly county-level data for 2003-2016 indicate that reductions in opium prices significantly increase the quantity of opioids prescribed. The increase...
Persistent link: https://www.econbiz.de/10012843718
Saved in:
First
Prev
2
3
4
5
6
7
8
9
10
11
Next
Last
Results per page
10
25
50
100
250
A service of the
zbw
×
Loading...
//-->